POSEIDON group prevalence in assisted reproductive technology cycles: A retrospective analysis from an Indian tertiary assisted reproductive technology center

Abstract

Objectives: The aim of the study was to assess the prevalence of “low prognosis” patients using POSEIDON criteria undergoing in vitro fertilization (IVF) cycle in Indian population. Study Design: This is a retrospective cohort study. Period of Study: It included data from the recruitment period from January 1, 2018 to December 31, 2021. Study Settings: The study was conducted at the Center for IVF and Human Reproduction, Sir Gangaram Hospital, New Delhi. Methodology: Out of the 3032 IVF stimulation cycles with oocyte aspirations, 596 cycles were excluded based on the exclusion criteria. The study focused on 2436 IVF/ICSI (Intracytoplasmic sperm injection) stimulation cycles that met inclusion criteria. Each cycle was categorized into one of the four groups defined by the POSEIDON criteria along with a fifth non-POSEIDON group. Prevalence was observed for each POSEIDON group and the non-POSEIDON group. Results: Out of the analyzed cycles, 1210 were classified under POSEIDON groups, representing a prevalence of 49.67%. The distribution of cycles in POSEIDON groups 1, 2, 3, and 4 was 31.4, 23.2, 19.17, and 26.19%, respectively. Conclusion: Low prognosis patients based on POSEIDON criteria, represented about half of the population.